Limitations of the histopathogical diagnosis and prognostic assessment of hepatocellular carcinoma

Keywords: hepatocellular carcinoma; small hepatocellular carcinoma; hepatocellular carcinoma with lymphoid stroma; fibrolamellar carcinoma; encapsulated hepatocellular carcinoma; regressing hepatocellular carcinoma; diagnosis; prognosis

[1]  A. Llombart‐Bosch,et al.  Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain , 1999, Virchows Archiv.

[2]  D. Nagorney,et al.  Primary hepatic malignancy: surgical management and determinants of survival. , 1989, Surgery.

[3]  H. Thomas,et al.  Increase in primary liver cancer in the UK, 1979–94 , 1997, The Lancet.

[4]  H. Altmann.  Some histological remarks on the fibrolamellar carcinoma of the liver. , 1990, Pathology, research and practice.

[5]  S. Taylor-Robinson,et al.  Increased mortality from liver cancer in England and Wales is not related to hepatitis C , 1999, BMJ.

[6]  M. Mizumoto,et al.  Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance , 1998, Hepatology.

[7]  J. Saric,et al.  Characterization of liver‐associated natural killer cells in patients with liver tumors , 1991, Hepatology.

[8]  B. Portmann,et al.  Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. , 1993, Journal of hepatology.

[9]  N. Nagasue,et al.  Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. , 1993, Gastroenterology.

[10]  J. Wands,et al.  The increasing incidence of hepatocellular carcinoma. , 1999, The New England journal of medicine.

[11]  T. Kasai,et al.  Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma , 1993, Cancer.

[12]  Y. Morioka,et al.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. , 1987 .

[13]  J. Going,et al.  Predicting the future: a critical appraisal of cancer prognosis studies , 1999, Histopathology.

[14]  Y. Nakanuma,et al.  Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. , 1998, Gastroenterology.

[15]  D. Adams,et al.  Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. , 1998, Journal of immunology.

[16]  M. Zoli,et al.  Transient spontaneous regression of hepatocellular carcinoma. , 1998, Hepato-gastroenterology.

[17]  C. Chastang,et al.  Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes , 1996, Cancer.

[18]  K. Omagari,et al.  Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis , 1998, Gut.

[19]  B. A. Levine.  Current practice of surgery , 1993 .

[20]  F. Holmes,et al.  Long survival and prognostic factors in hepatocellular carcinoma , 1990, Journal of surgical oncology.

[21]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[22]  N. Lemoine,et al.  Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting , 1999, The Journal of pathology.

[23]  J. Meakins,et al.  Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. , 1990, Gastroenterology.

[24]  P. Neuhaus,et al.  Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. , 1999, Anticancer research.

[25]  T. Saibara,et al.  Hitherto unrecognized arterioles within hepatocellular carcinoma , 1994, The Journal of pathology.

[26]  M. Kojiro,et al.  Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration , 1998, Hepatology.

[27]  E. Boerwinkle,et al.  Structure, Function, Molecular Genetics, and Epidemiology of Apolipoprotein B , 1992, Seminars in liver disease.

[28]  W. Olszewski,et al.  Liver Sinusoidal Blood Containing Natural Killer‐Like Cells , 1989, Scandinavian journal of immunology.

[29]  H. Leffert,et al.  A 43‐base‐pair complementary DNA sequence homology and triplet repeat motif among putative polymeric immunoglobulin receptor messenger RNAs in regenerating rat liver , 1993, Hepatology.

[30]  N. Toyota,et al.  Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. , 1998, Anticancer research.

[31]  J. Bruix,et al.  Liver transplantation for small hepatocellular carcinoma: The tumor‐node‐metastasis classification does not have prognostic power , 1998, Hepatology.

[32]  H. Yamamoto,et al.  Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. , 1997, Gastroenterology.

[33]  C. Saccone,et al.  p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. , 1998, British Journal of Cancer.

[34]  S. Amaki,et al.  Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma. , 2000, Journal of hepatology.

[35]  Zeng-chen Ma,et al.  Surgery of small hepatocellular carcinoma. Analysis of 144 cases , 1989, Cancer.

[36]  K. Engeland,et al.  Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. , 1999, Journal of the National Cancer Institute.

[37]  Y. Soini,et al.  Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. , 1996, British Journal of Cancer.

[38]  J. Bruix,et al.  Treatment of hepatocellular carcinoma. , 2006, Critical reviews in oncology/hematology.

[39]  E. Lai,et al.  Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen. , 1995, American journal of clinical pathology.

[40]  H. Hsu,et al.  Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC , 1985, Cancer.

[41]  Jeng-Jong Hwang,et al.  Ki‐67 expression as a prognostic marker in patients with hepatocellular carcinoma , 1998, Journal of gastroenterology and hepatology.

[42]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[43]  A. Lok,et al.  Long‐term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features , 1990, Hepatology.

[44]  K. Tanikawa,et al.  Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. , 1998, Human pathology.

[45]  I. Lauder,et al.  Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience , 2000, Hepatology.

[46]  C. Lai,et al.  Histologic prognostic indicators in hepatocellular carcinoma , 1979, Cancer.

[47]  L. Melton,et al.  Hepatoma in the noncirrhotic liver , 1988, Cancer.

[48]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[49]  J. Bruix,et al.  Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. , 1996, Annals of surgery.

[50]  N. Lemoine,et al.  Genomic heterogeneity in synchronous hepatocellular carcinomas , 1999, Gut.

[51]  H. Miyake,et al.  Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  T. Aihara,et al.  Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. , 1994, Gastroenterology.

[53]  D. V. van Thiel,et al.  Hepatic resection versus transplantation for hepatocellular carcinoma. , 1991, Annals of surgery.

[54]  M. Monden,et al.  Expression and prognostic roles of the G1‐S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence , 1999, Hepatology.

[55]  O. Yokosuka,et al.  Clonality in hepatocellular carcinoma: Analysis of methylation pattern of polymorphic X–chromosome‐linked phosphoglycerate kinase gene in females , 1995, Hepatology.

[56]  Noriyuki Moriyama,et al.  Pathology of small hepatocellular carcinoma. A proposal for a new gross classification , 1987, Cancer.

[57]  E. Moreno gonzález,et al.  Spontaneous regression of a recurrent hepatocellular carcinoma. , 1998, Digestive diseases and sciences.

[58]  P. Scheuer,et al.  The nomenclature of chronic hepatitis: time for a change. , 1995, Journal of hepatology.

[59]  A. Ariza,et al.  Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma , 1997, Histopathology.

[60]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[61]  H. Bismuth,et al.  Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation , 2000, Histopathology.

[62]  F. Callea,et al.  Pathology of hepatocellular carcinoma , 1993, Journal of surgical oncology. Supplement.

[63]  G. Stansby,et al.  Surgery of small hepatocellular carcinoma. , 1990, Cancer.

[64]  V. Paradis,et al.  Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X‐chromosome inactivation , 1997, Hepatology.

[65]  M. Sherman,et al.  Small encapsulated hepatocellular carcinoma of the liver provisional analysis of pathogenetic mechanisms , 1993, Cancer.

[66]  P. Anthony,et al.  Pedunculated hepatocellular carcinoma. Is it an entity? , 1987, Histopathology.

[67]  K. Ishak,et al.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. , 1996, American journal of clinical pathology.

[68]  H. Asakura,et al.  Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver. , 1998, Hepatology.

[69]  K. Dewbury,et al.  Spontaneous regression of hepatocellular carcinoma. , 1990, Gut.

[70]  C. Tiribelli,et al.  Prevalence of hepatocellular carcinoma and relation to cirrhosis: Comparison of two different cities of the world—Trieste, Italy, and Chiba, Japan , 1989, Hepatology.

[71]  M. Kojiro,et al.  Clinicopathologic features of encapsulated hepatocellular carcinoma. A study of 26 cases , 1977, Cancer.

[72]  M. Manns,et al.  Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  H. Hsu,et al.  Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. , 1998, Journal of hepatology.

[74]  J. Welsh,et al.  Fingerprinting genomes using PCR with arbitrary primers. , 1990, Nucleic acids research.

[75]  Z. Piao,et al.  Clonality of large regenerative nodules in liver cirrhosis. , 2008, Liver.

[76]  E. Rosato,et al.  The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia , 1987, Cancer.

[77]  M. Monden,et al.  Clonal analysis of precancerous lesion of hepatocellular carcinoma. , 1996, Gastroenterology.

[78]  S. Fan,et al.  Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patients , 1995, Cancer.

[79]  B. Sepúlveda,et al.  [Primary carcinoma of the liver]. , 1952, Gaceta medica de Mexico.

[80]  P. Scheuer,et al.  An immunohistochemical study of the blood vessels within primary hepatocellular tumours. , 2008, Liver.

[81]  T Nakamura,et al.  Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. , 1993, Gastroenterology.

[82]  E. Stoelben,et al.  Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature , 1998, Langenbeck's Archives of Surgery.

[83]  H. Hsu,et al.  Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications , 1988, Cancer.

[84]  [Estimation of cell proliferation in hepatocellular carcinoma and in background liver cirrhosis, by using MIB-1 LI]. , 1998, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[85]  Hansson,et al.  Spontaneous regression of hepatocellular carcinoma , 1998, Histopathology.

[86]  A. Tannapfel,et al.  Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma , 1999, The Journal of pathology.